FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Patricia Armatis

Research Profile

Chemicals & Drugs

Anatomy

Tumor Cells, Cultured

Living Beings

Physiology

Cell Divisions

Procedures

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Marta Zarandi; Jozsef Varga; Andrew V Schally; Judit E Horvath; Gabor L Toller; Magdolna Kovacs; Markus Letsch; Kate Groot; Patricia Armatis; Gabor Halmos
Lipopeptide antagonists of growth hormone-releasing hormone with improved antitumor activities.
Anton Stangelberger; Andrew V Schally; Jozsef Varga; Marta Zarandi; Renzhi Cai; Ben Baker; Brian D Hammann; Patricia Armatis; Celia A Kanashiro
Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling.
Gunhild Keller; Andrew V Schally; Kate Groot; Gabor L Toller; Alexandre Havt; Frank Köster; Patricia Armatis; Gabor Halmos; Marta Zarandi; Jozsef Varga; Jörg Engel
Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormone.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Patricia Armatis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2006: Marta Zarandi; Jozsef Varga; Andrew V Schally; Judit E Horvath; Gabor L Toller; Magdolna Kovacs; Markus Letsch; Kate Groot; Patricia Armatis; Gabor Halmos
Lipopeptide antagonists of growth hormone-releasing hormone with improved antitumor activities.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(12):4610-5.
2005: Anton Stangelberger; Andrew V Schally; Jozsef Varga; Marta Zarandi; Renzhi Cai; Ben Baker; Brian D Hammann; Patricia Armatis; Celia A Kanashiro
Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling.
European journal of cancer (Oxford, England : 1990) 2005;41(17):2735-44.
2005: Gunhild Keller; Andrew V Schally; Kate Groot; Gabor L Toller; Alexandre Havt; Frank Köster; Patricia Armatis; Gabor Halmos; Marta Zarandi; Jozsef Varga; Jörg Engel
Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormone.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(30):10628-33.
2005: Jörg Engel; Gunhild Keller; Andrew V Schally; Gabor L Toller; Kate Groot; Alexandre Havt; Patricia Armatis; Marta Zarandi; Jozsef Varga; Gabor Halmos
Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormone.
The Journal of clinical endocrinology and metabolism 2005;90(6):3614-21.
2005: Anton Stangelberger; Andrew V Schally; Jozsef Varga; Marta Zarandi; Karoly Szepeshazi; Patricia Armatis; Gabor Halmos
Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):49-57.
2003: Celia A Kanashiro; Andrew V Schally; Kate Groot; Patricia Armatis; Andrea L F Bernardino; Jozsef Varga
Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(26):15836-41.
2003: Zoltan Szereday; Andrew V Schally; Jozsef Varga; Celia A Kanashiro; Francine Hebert; Patricia Armatis; Kate Groot; Karoly Szepeshazi; Gabor Halmos; Rebeca Busto
Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma.
Cancer research 2003;63(22):7913-9.
2002: Magdolna Kovacs; Andrew V Schally; E-J Lee; Rebeca Busto; Patricia Armatis; Kate Groot; Jozsef Varga
Inhibitory effects of antagonistic analogs of GHRH on GH3 pituitary cells overexpressing the human GHRH receptor.
The Journal of endocrinology 2002;175(2):425-34.
2002: Ryszard Braczkowski; Andrew V Schally; Artur Plonowski; Jozsef Varga; Kate Groot; Magdalena Krupa; Patricia Armatis
Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
Cancer 2002;95(8):1735-45.
2002: Rebeca Busto; Andrew V Schally; Ryszard Braczkowski; Artur Plonowski; Magdalena Krupa; Kate Groot; Patricia Armatis; Jozsef Varga
Expression of mRNA for growth hormone-releasing hormone and splice variants of GHRH receptors in human malignant bone tumors.
Regulatory peptides 2002;108(2-3):47-53.
2002: Rebeca Busto; Andrew V Schally; Jozsef Varga; M Olga Garcia-Fernandez; Kate Groot; Patricia Armatis; Karoly Szepeshazi
The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(18):11866-71.
2002: Karoly Szepeshazi; Andrew V Schally; Gabor Halmos; Patricia Armatis; Francine Hebert; Baodong Sun; Anita Feil; Hippokratis Kiaris; Attila Nagy
Targeted cytotoxic somatostatin analogue AN-238 inhibits somatostatin receptor-positive experimental colon cancers independently of their p53 status.
Cancer research 2002;62(3):781-8.
2001: Ioulia Chatzistamou; Andrew V Schally; Jozsef Varga; Kate Groot; Patricia Armatis; Ana M Bajo
Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.
Journal of cancer research and clinical oncology 2001;127(11):645-52.
2001: Ioulia Chatzistamou; Andrew V Schally; Jozsef Varga; Kate Groot; Rebeca Busto; Patricia Armatis; Gabor Halmos
Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone.
Anti-cancer drugs 2001;12(9):761-8.
2001: Karoly Szepeshazi; Andrew V Schally; Patricia Armatis; Kate Groot; Francine Hebert; A Feil; Jozsef Varga; Gabor Halmos
Antagonists of GHRH decrease production of GH and IGF-I in MXT mouse mammary cancers and inhibit tumor growth.
Endocrinology 2001;142(10):4371-8.
2001: Zoltan Rekasi; Jozsef Varga; Andrew V Schally; Artur Plonowski; Gabor Halmos; Balazs Csernus; Patricia Armatis; Kate Groot
Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways.
Peptides 2001;22(6):879-86.
2001: Ioulia Chatzistamou; Andrew V Schally; Jozsef Varga; Kate Groot; Patricia Armatis; Rebeca Busto; Gabor Halmos
Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice.
The Journal of clinical endocrinology and metabolism 2001;86(5):2144-52.
2001: Hippokratis Kiaris; Andrew V Schally; Patricia Armatis
Direct action of growth hormone-releasing hormone agonist JI-38 on normal human fibroblasts: evidence from studies on cell proliferation and c-myc proto-oncogene expression.
Regulatory peptides 2001;96(3):119-24.
2000: L Chatzistamou; Andrew V Schally; Attila Nagy; Patricia Armatis; Karoly Szepeshazi; Gabor Halmos
Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(10):4158-65.
2000: Ioulia Chatzistamou; Andrew V Schally; Baodong Sun; Patricia Armatis; Karoly Szepeshazi
Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists.
British journal of cancer 2000;83(7):906-13.
2000: Zoltan Rekasi; Jozsef Varga; Andrew V Schally; Gabor Halmos; Patricia Armatis; Kate Groot; Tamas Czompoly
Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancers.
Endocrinology 2000;141(6):2120-8.
2000: Karoly Szepeshazi; Andrew V Schally; Kate Groot; Patricia Armatis; Gabor Halmos; F Herbert; Béla Szende; Jozsef Varga; Marta Zarandi
Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers.
British journal of cancer 2000;82(10):1724-31.
2000: Z Kahán; Jozsef Varga; Andrew V Schally; Z Rékási; Patricia Armatis; L Chatzistamou; T Czömpöly; Gabor Halmos
Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice.
Breast cancer research and treatment 2000;60(1):71-9.
2000: Karoly Szepeshazi; Andrew V Schally; Kate Groot; Patricia Armatis; Francine Hebert; Gabor Halmos
Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours.
European journal of cancer (Oxford, England : 1990) 2000;36(1):128-36.
1999: Hippokratis Kiaris; Andrew V Schally; Jozsef Varga; Kate Groot; Patricia Armatis
Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(26):14894-8.
1999: Hippokratis Kiaris; Andrew V Schally; Baodong Sun; Patricia Armatis; Kate Groot
Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide.
Oncogene 1999;18(50):7168-73.
1999: Hippokratis Kiaris; Andrew V Schally; Attila Nagy; Baodong Sun; Patricia Armatis; Karoly Szepeshazi
Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice.
British journal of cancer 1999;81(6):966-71.
1999: M Miyazaki; Andrew V Schally; Attila Nagy; N Lamharzi; Gabor Halmos; Karoly Szepeshazi; Patricia Armatis
Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice.
American journal of obstetrics and gynecology 1999;180(5):1095-103.
1999: VJ Csernus; Andrew V Schally; Hippokratis Kiaris; Patricia Armatis
Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(6):3098-103.
1998: Andreas Jungwirth; Andrew V Schally; Gabor Halmos; Kate Groot; Karoly Szepeshazi; Jacek Pinski; Patricia Armatis
Inhibition of the growth of Caki-I human renal adenocarcinoma in vivo by luteinizing hormone-releasing hormone antagonist Cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II.
Cancer 1998;82(5):909-17.
1998: N Lamharzi; Gabor Halmos; Patricia Armatis; Andrew V Schally
Expression of mRNA for luteinizing hormone-releasing hormone receptors and epidermal growth factor receptors in human cancer cell lines.
International journal of oncology 1998;12(3):671-5.
1998: Attila Nagy; Andrew V Schally; Gabor Halmos; Patricia Armatis; Renzhi Cai; VJ Csernus; M Kovács; M Koppán; K Szepesházi; Z Kahán
Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(4):1794-9.
1997: M Miyazaki; Attila Nagy; Andrew V Schally; N Lamharzi; Gabor Halmos; Karoly Szepeshazi; Kate Groot; Patricia Armatis
Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone.
Journal of the National Cancer Institute 1997;89(23):1803-9.
1997: Andreas Jungwirth; Andrew V Schally; Jacek Pinski; Kate Groot; Patricia Armatis; Gabor Halmos
Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(11):5810-3.
1997: Attila Nagy; Patricia Armatis; Renzhi Cai; Karoly Szepeshazi; Gabor Halmos; Andrew V Schally
Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(2):652-6.
1997: Andreas Jungwirth; Andrew V Schally; Jacek Pinski; Gabor Halmos; Kate Groot; Patricia Armatis; M Vadillo-Buenfil
Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone.
British journal of cancer 1997;75(11):1585-92.
1996: Attila Nagy; Andrew V Schally; Patricia Armatis; Karoly Szepeshazi; Gabor Halmos; Magdolna Kovacs; Marta Zarandi; Kate Groot; M Miyazaki; Andreas Jungwirth; J Horvath
Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(14):7269-73.
1996: Attila Nagy; Patricia Armatis; Andrew V Schally
High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(6):2464-9.
1995: Jacek Pinski; Andrew V Schally; Kate Groot; Gabor Halmos; Karoly Szepeshazi; Marta Zarandi; Patricia Armatis
Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone.
Journal of the National Cancer Institute 1995;87(23):1787-94.
1994: Renzhi Cai; H Reile; Patricia Armatis; Andrew V Schally
Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(26):12664-8.
1994: H Reile; Patricia Armatis; Andrew V Schally
Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells.
The Prostate 1994;25(1):29-38.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.